pens – Lab DB

Pens to pills: what oral GLP-1s change at the bench

Lana Keisha Jul 23, 2026 0

The pharmaceutical landscape for metabolic diseases is undergoing a profound transformation, heralded by the recent approval of orforglipron, the first…

Pens to Pills: The Transformative Era of Oral GLP-1 Receptor Agonists in Drug Discovery and Patient Care

Lana Keisha Jul 16, 2026 0

The pharmaceutical landscape for metabolic diseases has reached a pivotal inflection point, marked by the recent approval of the first…

Pens to pills: what oral GLP-1s change at the bench

Lana Keisha Jun 30, 2026 0

The pharmaceutical landscape for metabolic disorders is undergoing a profound transformation, heralded by the advent of oral small-molecule GLP-1 receptor…

Pens to pills: what oral GLP-1s change at the bench

Pens to Pills: The Transformative Era of Oral GLP-1 Receptor Agonists in Drug Discovery and Patient Care

Pens to pills: what oral GLP-1s change at the bench

YOU MAY HAVE MISSED

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation